These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 32953993)

  • 1. SARS-CoV-2 and EBV coinfection.
    García-Martínez FJ; Moreno-Artero E; Jahnke S
    Med Clin (Engl Ed); 2020 Oct; 155(7):319-320. PubMed ID: 32953993
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report.
    Rodriguez JA; Rubio-Gomez H; Roa AA; Miller N; Eckardt PA
    IDCases; 2020; 20():e00762. PubMed ID: 32368493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients.
    Liang L; He C; Lei M; Li S; Hao Y; Zhu H; Duan Q
    DNA Cell Biol; 2005 Aug; 24(8):485-90. PubMed ID: 16101345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.
    Shirvani E; Samal SK
    Pathogens; 2020 Jul; 9(8):. PubMed ID: 32751194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity.
    Ejemel M; Li Q; Hou S; Schiller ZA; Wallace AL; Amcheslavsky A; Yilmaz NK; Toomey JR; Schneider R; Close BJ; Chen DY; Conway HL; Mohsan S; Cavacini LA; Klempner MS; Schiffer CA; Wang Y
    bioRxiv; 2020 May; ():. PubMed ID: 32511396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatical study on the proteomics and evolution of SARS-CoV.
    Liu S; Guo T; Ji X; Sun Z
    Chin Sci Bull; 2003; 48(13):1277-1287. PubMed ID: 32214704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Microbial Co-infection With SARS-CoV-2.
    Massey BW; Jayathilake K; Meltzer HY
    Front Microbiol; 2020; 11():2079. PubMed ID: 32983056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2.
    Zhu J; Kim J; Xiao X; Wang Y; Luo D; Jiang S; Chen R; Xu L; Zhang H; Moise L; Gutierrez AH; De Groot AS; Xiao G; Schoggins JW; Zhan X; Wang T; Xie Y
    bioRxiv; 2020 Sep; ():. PubMed ID: 32908981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience.
    Huang J; Zheng M; Tang X; Chen Y; Tong A; Zhou L
    Front Neurol; 2020; 11():659. PubMed ID: 32625165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogeny of SARS-CoV as inferred from complete genome comparison.
    Qi Z; Hu Y; Li W; Chen Y; Zhang Z; Sun S; Lu H; Zhang J; Bu D; Ling L; Chen R
    Chin Sci Bull; 2003; 48(12):1175-1178. PubMed ID: 32214702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
    Prathiviraj R; Kiran GS; Selvin J
    Gene Rep; 2020 Sep; 20():100777. PubMed ID: 32835133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.
    Vavougios GD
    Infect Genet Evol; 2020 Dec; 86():104602. PubMed ID: 33132111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.
    Paolucci S; Cassaniti I; Novazzi F; Fiorina L; Piralla A; Comolli G; Bruno R; Maserati R; Gulminetti R; Novati S; Mojoli F; Baldanti F;
    Int J Infect Dis; 2021 Mar; 104():315-319. PubMed ID: 33359064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Cytomegalovirus Co-infection: A Challenging Case of a Critically Ill Patient with Gastrointestinal Symptoms.
    Amaral PH; Ferreira BM; Roll S; Neves PD; Pivetta LG; Mohrbacher S; Dias ER; Sato VA; Oliveira ÉS; Pereira LV; Bales AM; Nardotto LL; Ferreira JN; Cuvello-Neto AL; Chocair PR
    Eur J Case Rep Intern Med; 2020; 7(10):001911. PubMed ID: 33083369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
    Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
    Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19.
    Lehner GF; Klein SJ; Zoller H; Peer A; Bellmann R; Joannidis M
    Crit Care; 2020 Nov; 24(1):657. PubMed ID: 33228750
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral facial nerve palsy associated with COVID-19 and Epstein-Barr virus co-infection.
    Cabrera Muras A; Carmona-Abellán MM; Collía Fernández A; Uterga Valiente JM; Antón Méndez L; García-Moncó JC
    Eur J Neurol; 2021 Jan; 28(1):358-360. PubMed ID: 32997868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
    Chen T; Song J; Liu H; Zheng H; Chen C
    Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
    Drago F; Ciccarese G; Rebora A; Parodi A
    J Med Virol; 2021 Apr; 93(4):1850-1851. PubMed ID: 32970319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.